Market Tracker

09/19 6:35pm ET

Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

161.44
Data as of Sep 19
 -0.12 / -0.07%
Today’s Change
100.89
Today|||52-Week Range
185.43
+21.49%
Year-to-Date

Today’s Trading

Previous close161.56
Today’s open162.80
Day’s range159.28 - 163.50
Volume3,092,096
Average volume (3 months)1,172,650
Market cap$32.0B
Dividend yield--
Data as of 3:59pm ET, 09/19/2014

Growth & Valuation

Earnings growth (last year)-0.78%
Earnings growth (this year)+62.98%
Earnings growth (next 5 years)+26.55%
Revenue growth (last year)+34.85%
P/E ratio81.5
Price/Sales17.19
Price/Book13.36

Competitors

 Today’s
change
Today’s
% change
VRXValeant Pharmaceutic...-3.09-2.56%
VRTXVertex Pharmaceutica...+6.40+6.57%
PRGOPerrigo Company PLC+0.63+0.43%
ZTSZoetis Inc+0.50+1.36%
Data as of 4:05pm ET, 09/19/2014

Financials

Next reporting dateOctober 23, 2014
EPS forecast (this quarter)$1.16
Annual revenue (last year)$1.5B
Annual profit (last year)$252.9M
Net profit margin16.73%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer, Treasurer &
Director
Leonard Bell
Chief Operating Officer &
Director
David L. Hallal
Corporate headquarters
Cheshire, Connecticut

Forecasts